Literature DB >> 23544880

The distribution and functional properties of Pelizaeus-Merzbacher-like disease-linked Cx47 mutations on Cx47/Cx47 homotypic and Cx47/Cx43 heterotypic gap junctions.

Mi Seong Kim1, Gregory B Gloor, Donglin Bai.   

Abstract

GJs (gap junctions) allow direct intercellular communication, and consist of Cxs (connexins). In the mammalian central nervous system, oligodendrocytes express Cx47, Cx32 and Cx29, whereas astrocytes express Cx43, Cx30 and Cx26. Homotypic Cx47/Cx47 GJs couple oligodendrocytes, and heterotypic Cx47/Cx43 channels are the primary GJs at oligodendrocyte/astrocyte junctions. Interestingly, autosomal recessive mutations in the gene GJC2 encoding Cx47 have been linked to a central hypomyelinating disease termed PMLD (Pelizaeus-Merzbacher-like disease). The aim of the present study was to determine the cellular distribution and functional properties of PMLD-associated Cx47 mutants (I46M, G149S, G236R, G236S, M286T and T398I). Expressing GFP (green fluorescent protein)-tagged mutant versions of Cx47 in gap-junction-deficient model cells revealed that these mutants were detected at the cell-cell interface similar to that observed for wild-type Cx47. Furthermore, four of the six mutants showed no electrical coupling in both Cx47/Cx47 and Cx47/Cx43 GJ channels. These results suggest that most of the PMLD-linked Cx47 mutants disrupt Cx47/Cx47 and Cx47/Cx43 GJ function in the glial network, which may play a role in leading to PMLD symptoms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23544880     DOI: 10.1042/BJ20121821

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  8 in total

Review 1.  Therapeutic strategies targeting connexins.

Authors:  Dale W Laird; Paul D Lampe
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

2.  Cx47 fine-tunes the handling of serum lipids but is dispensable for lymphatic vascular function.

Authors:  Merlijn J Meens; Issa Kutkut; Viviane Rochemont; Juan Dubrot; Fouad R Kaladji; Amélie Sabine; Oliver Lyons; Stefanie Hendrikx; Jeremiah Bernier-Latmani; Friedemann Kiefer; Alberto Smith; Stéphanie Hugues; Tatiana V Petrova; Brenda R Kwak
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

3.  Mechanisms of Connexin-Related Lymphedema.

Authors:  Jorge A Castorena-Gonzalez; Scott D Zawieja; Min Li; R Sathish Srinivasan; Alexander M Simon; Cor de Wit; Roger de la Torre; Luis A Martinez-Lemus; Grant W Hennig; Michael J Davis
Journal:  Circ Res       Date:  2018-09-28       Impact factor: 17.367

4.  Connexin 46 and connexin 50 gap junction channel properties are shaped by structural and dynamic features of their N-terminal domains.

Authors:  Benny Yue; Bassam G Haddad; Umair Khan; Honghong Chen; Mena Atalla; Ze Zhang; Daniel M Zuckerman; Steve L Reichow; Donglin Bai
Journal:  J Physiol       Date:  2021-05-13       Impact factor: 6.228

Review 5.  Connexin: a potential novel target for protecting the central nervous system?

Authors:  Hong-Yan Xie; Yu Cui; Fang Deng; Jia-Chun Feng
Journal:  Neural Regen Res       Date:  2015-04       Impact factor: 5.135

6.  Dysfunction of the oligodendrocytes in amyotrophic lateral sclerosis.

Authors:  Zhenxiang Gong; Li Ba; Min Zhang
Journal:  J Biomed Res       Date:  2022-08-28

7.  Ultrastructure of gap junction and Cx43 expression in gastric cancer tissues of the patients.

Authors:  Chun-Hui Li; Mei-Ling Hao; Yu Sun; Zhu-Jun Wang; Jian-Ling Li
Journal:  Arch Med Sci       Date:  2020-02-04       Impact factor: 3.318

8.  Dysregulation of Blood-Brain Barrier and Exacerbated Inflammatory Response in Cx47-Deficient Mice after Induction of EAE.

Authors:  Filippos Stavropoulos; Elena Georgiou; Irene Sargiannidou; Kleopas A Kleopa
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.